September 15, 2014 10:01 PM ET

Healthcare Providers and Services

Company Overview of N-of-One Therapeutics, Inc.

Company Overview

N-of-One Therapeutics, Inc. provides clinical analysis, curation, and interpretation of a tumor's molecular profile to providers, diagnostic companies, individual physicians, and cancer patients. The company’s solutions include treatment strategy roadmaps, clinical trial matching, and diagnostic strategy roadmaps. Its solutions and services pivot on matching patient-specific tumor molecular profiling data with knowledge on diagnostic technologies and therapeutic options to identify relevant clinical strategies for each patient's unique cancer. The company supports oncologists by delivering content and clinical insights for cancer treatment decisions and diagnostic approaches. N-of-One Therap...

430 Bedford Street

Suite 390

Lexington, MA 02420

United States

Founded in 2007





Key Executives for N-of-One Therapeutics, Inc.

Chairman and Chief Executive Officer
Age: 62
Chief Financial Officer
Chief Technology Officer
Scientific Director
Compensation as of Fiscal Year 2014.

N-of-One Therapeutics, Inc. Key Developments

CeGaT Selects N-of-One to Provide Clinical Interpretation for Next-Generation Sequencing Tests

CeGaT has announced an agreement with N-of-One, Inc. Under this agreement, N-of-One will provide clinical interpretation for CeGaT's next-generation sequencing (NGS) tests done for cancer patients. Financial terms of the agreement are not disclosed. CeGaT has developed a next-generation sequencing panel to analyze more than 550 cancer-relevant genes in a tumor sample simultaneously. Knowledge about the relevant mutations in a tumor helps clinicians select the most effective therapeutic strategies. CeGaT is partnering with N-of-One to provide high quality, up-to-date interpretation of mutations with very rapid turnaround times.

N-of-One Announces Agreement with Mayo Clinic to Provide Clinical Interpretation Support for Molecular Diagnostics Program

N-of-One announced an agreement with Mayo Clinic to provide access to clinical interpretation information to aid in highly complex molecular diagnostics. Under the terms of the agreement, in select cases, N-of-One solutions will assist in the identification of biological and clinical knowledge, therapeutic options, and potential clinical trials for patients who undergo next generation cancer sequencing. This will help to translate knowledge specifically related to individual patients' tumors into molecularly informed, personalized treatment decisions. Mayo Clinic will use the clinical interpretation services for Mayo Medical Laboratories, a global reference laboratory operating within Mayo Clinic's Department of Laboratory Medicine and Pathology, as well as in its Center for Individualized Medicine, which discovers and integrates the latest in genomic, molecular and clinical sciences into personalized care for each Mayo Clinic patient.

N-of-One Announces Agreement with Guardant Health to Provide Clinical Decision Support for Guardant360

N-of-One announced an agreement with Guardant Health to provide clinical decision support for Guardant360, a breakthrough blood test that enables next generation sequencing of solid tumor DNA. N-of-One's clinical interpretation provides relevant biological and clinical knowledge related to the mutation profile of the identified tumor DNA, and links this knowledge to relevant therapeutic strategies, including clinical trials, to support oncologists in making molecularly-informed, personalized treatment decisions.

Similar Private Companies By Industry

Company Name Region
Central Carolina Surgical Eye Associates, P.A. United States
Iowa Health System, Inc. United States
REM Southwest Services, Inc. United States
VHS Children's Hospital of Michigan, Inc. United States
Butler HealthCorp, Inc. United States

Recent Private Companies Transactions

Private Placement
December 16, 2013

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact N-of-One Therapeutics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at